We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
GS or MS: Which IB Stock Should You Buy on Solid 2026 Prospects?
Read MoreHide Full Article
Key Takeaways
Goldman's IB revenues rose 19% in the first nine months of 2025 as global M&A and issuance rebounded.
Morgan Stanley's IB activity improved in 2025, driven by rate-cut optimism and renewed deal momentum.
Morgan Stanley's wealth and asset management adds stability, with client assets reaching $8.9 trillion.
When it comes to Wall Street heavyweights, there are not many names that wield more influence than Goldman (GS - Free Report) and Morgan Stanley (MS - Free Report) . Both are global financial leaders with strong investment banking expertise, advising on major mergers, underwriting high-profile IPOs, and guiding clients through complex capital markets.
After a few years of subdued volumes and episodic deal-making, 2025 marked a solid revival of global mergers and acquisitions (M&As) due to clarity on several macro issues and easing monetary policy. While investor confidence was shaken in April following the announcement of “Liberation Day” tariff plans, things improved in the second half of the year. A strong U.S. economy, a more accommodating regulatory environment under Trump, clearer trade policies and the Federal Reserve’s rate cuts have improved the operating environment for the capital markets business. Against this, which IB powerhouse – Goldman or Morgan Stanley – is a smarter bet for 2026? Let’s decipher this.
The Case for Goldman
Goldman is a dominant player in M&A, trading and capital markets. For the first nine months of 2025, the company’s IB revenues rose 19% year over year, supported by a rebound in global M&A activity and capital markets issuance. Throughout 2025, its IB division has capitalized on the resurgence in global deal-making, advising on more than $1 trillion in announced M&A volumes.
David Solomon, chairman and CEO of Goldman, highlighted improvements in M&A throughout the year and expects the constructive environment to persist, with stronger M&A activity anticipated in 2026 amid a favorable backdrop.
Further, GS has embarked on a deliberate transformation to exit non-core consumer banking and double down on the divisions where it maintains a clear competitive advantage. Hence, the company is accelerating expansion in the asset and wealth management business. In December, Goldman agreed to acquire Innovator Capital Management to expand active ETF capabilities, while, in October, it agreed to buy Industry Ventures to expand its exposure to the innovation economy and solidify its position in the global alternatives market. Moreover, in September, Goldman expanded its alliance with T. Rowe Price to give individuals greater access to private markets, with new offerings set for launch in phases.
Goldman plans to ramp up its lending services to private equity and asset managers and expand internationally. The company's asset management unit intends to expand its private credit portfolio to $300 billion by 2029. Management expects to witness high-single-digit annual growth in private banking and lending revenues over time.
The Case for Morgan Stanley
Morgan Stanley has leaned heavily into the IB business, although it has been diversifying into more stable revenue-generating sources like asset and wealth management businesses, creating a more balanced revenue stream across market cycles. Similar to GS, the company’s IB performance improved in the first nine months of 2025, driven by trade clarity and optimism surrounding interest rate cuts.
Ted Pick, chairman and CEO of Morgan Stanley, said the rebound in the operating environment enabled strategic M&A and renewed financing activity. While he remained cautious, remarking that “whether we are entering a golden age of investment banking remains to be seen,” he affirmed that IB activity should trend upward over the next couple of years. Hence, given the improving macroeconomic scenario, MS will be able to capitalize on it.
Also, Morgan Stanley’s partnership with Mitsubishi UFJ Financial Group, Inc. will continue to support profitability. With further solidification of this collaboration in 2023, the company’s market share in Japan has improved. The company’s Asia region revenues jumped 29.3% year over year to $7.27 billion during the first nine months of 2025.
As mentioned above, MS is focusing on expanding its wealth and asset management operations, which supported its financials during the post-pandemic slowdown in the IB business. In sync with this initiative, in October, the company announced a deal to acquire EquityZen in an effort to tap the rapidly growing private markets landscape. Earlier, it acquired Eaton Vance, E*Trade Financial and Shareworks, which lowered its dependence on the capital markets business. The wealth and asset management businesses’ aggregate contribution to total net revenues jumped to more than 55% in 2024 from 26% in 2010. The momentum continued this year, with total client assets across both segments reaching $8.9 trillion by September-end. This brings Morgan Stanley closer to its longstanding goal of $10 trillion in asset management set by former CEO James Gorman.
GS & MS: Price Performance, Valuation & Other Comparisons
Over the past six months, shares of Goldman and Morgan Stanley have gained 35.8% and 32.3%, respectively.
GS & MS Six-Month Price Performance
Image Source: Zacks Investment Research
Both outpaced the Zacks Investment Bank industry and the S&P 500 Index. In terms of investor sentiments, Goldman clearly has the edge over MS.
In terms of valuation, Goldman is currently trading at a 12-month forward price-to-earnings (P/E) of 16.34X. The MS stock, on the other hand, is currently trading at a 12-month forward P/E of 17.29X.
P/E F12M
Image Source: Zacks Investment Research
Further, both are trading at a premium compared with the industry average of 15.09X. So, Goldman is inexpensive compared with Morgan Stanley.
GS’s dividend yield of 1.78% is lower than Morgan Stanley’s 2.23%. Moreover, GS’ dividend yield is lower than the industry’s average dividend yield of 1.79%, while Morgan Stanley offers a superior dividend yield than the industry.
Dividend Yield
Image Source: Zacks Investment Research
Further, Goldman’s return on equity (ROE) of 15.29% is below Morgan Stanley’s 16.4%. This reflects Morgan Stanley’s efficient use of shareholder funds to generate profits.
ROE
Image Source: Zacks Investment Research
How Do Estimates Compare for GS & MS?
The Zacks Consensus Estimate for GS’ 2025 revenues implies a 10.8% year-over-year rise, while for 2026, the metric is expected to grow 6%. Likewise, the consensus estimate for 2025 earnings indicates 20.8% growth, while the same is anticipated to rise 12.6% in 2026. Earnings estimates for both years have been revised upward over the past seven days.
Estimate Revision
Image Source: Zacks Investment Research
On the contrary, analysts are slightly more bullish on Morgan Stanley’s prospects this year. The consensus mark for 2025 and 2026 revenues suggests a year-over-year jump of 13.4% and 4.4%, respectively. Also, the consensus estimate for earnings suggests a 24.3% and 5.4% increase for 2025 and 2026, respectively. Earnings estimates for both years have been revised upward over the past week.
Estimate Revision
Image Source: Zacks Investment Research
Goldman or Morgan Stanley: Which IB Stock is a Smarter Bet?
Goldman’s organic efforts to grow its IB income and strategic buyouts alongside efforts to strengthen the AWM segment are likely to bolster its financials. Further, its attractive valuation can offer a higher margin of safety for value investors.
By contrast, Morgan Stanley offers greater upside potential, driven by stronger projected revenue and earnings growth, a robust deal pipeline and continued expansion in wealth and asset management. Despite its higher valuation, the success of its strategic diversification efforts, superior dividend yield and capital allocation make it an attractive pick for long-term, growth-oriented investors.
Image: Bigstock
GS or MS: Which IB Stock Should You Buy on Solid 2026 Prospects?
Key Takeaways
When it comes to Wall Street heavyweights, there are not many names that wield more influence than Goldman (GS - Free Report) and Morgan Stanley (MS - Free Report) . Both are global financial leaders with strong investment banking expertise, advising on major mergers, underwriting high-profile IPOs, and guiding clients through complex capital markets.
After a few years of subdued volumes and episodic deal-making, 2025 marked a solid revival of global mergers and acquisitions (M&As) due to clarity on several macro issues and easing monetary policy. While investor confidence was shaken in April following the announcement of “Liberation Day” tariff plans, things improved in the second half of the year. A strong U.S. economy, a more accommodating regulatory environment under Trump, clearer trade policies and the Federal Reserve’s rate cuts have improved the operating environment for the capital markets business. Against this, which IB powerhouse – Goldman or Morgan Stanley – is a smarter bet for 2026? Let’s decipher this.
The Case for Goldman
Goldman is a dominant player in M&A, trading and capital markets. For the first nine months of 2025, the company’s IB revenues rose 19% year over year, supported by a rebound in global M&A activity and capital markets issuance. Throughout 2025, its IB division has capitalized on the resurgence in global deal-making, advising on more than $1 trillion in announced M&A volumes.
David Solomon, chairman and CEO of Goldman, highlighted improvements in M&A throughout the year and expects the constructive environment to persist, with stronger M&A activity anticipated in 2026 amid a favorable backdrop.
Further, GS has embarked on a deliberate transformation to exit non-core consumer banking and double down on the divisions where it maintains a clear competitive advantage. Hence, the company is accelerating expansion in the asset and wealth management business. In December, Goldman agreed to acquire Innovator Capital Management to expand active ETF capabilities, while, in October, it agreed to buy Industry Ventures to expand its exposure to the innovation economy and solidify its position in the global alternatives market. Moreover, in September, Goldman expanded its alliance with T. Rowe Price to give individuals greater access to private markets, with new offerings set for launch in phases.
Goldman plans to ramp up its lending services to private equity and asset managers and expand internationally. The company's asset management unit intends to expand its private credit portfolio to $300 billion by 2029. Management expects to witness high-single-digit annual growth in private banking and lending revenues over time.
The Case for Morgan Stanley
Morgan Stanley has leaned heavily into the IB business, although it has been diversifying into more stable revenue-generating sources like asset and wealth management businesses, creating a more balanced revenue stream across market cycles. Similar to GS, the company’s IB performance improved in the first nine months of 2025, driven by trade clarity and optimism surrounding interest rate cuts.
Ted Pick, chairman and CEO of Morgan Stanley, said the rebound in the operating environment enabled strategic M&A and renewed financing activity. While he remained cautious, remarking that “whether we are entering a golden age of investment banking remains to be seen,” he affirmed that IB activity should trend upward over the next couple of years. Hence, given the improving macroeconomic scenario, MS will be able to capitalize on it.
Also, Morgan Stanley’s partnership with Mitsubishi UFJ Financial Group, Inc. will continue to support profitability. With further solidification of this collaboration in 2023, the company’s market share in Japan has improved. The company’s Asia region revenues jumped 29.3% year over year to $7.27 billion during the first nine months of 2025.
As mentioned above, MS is focusing on expanding its wealth and asset management operations, which supported its financials during the post-pandemic slowdown in the IB business. In sync with this initiative, in October, the company announced a deal to acquire EquityZen in an effort to tap the rapidly growing private markets landscape. Earlier, it acquired Eaton Vance, E*Trade Financial and Shareworks, which lowered its dependence on the capital markets business. The wealth and asset management businesses’ aggregate contribution to total net revenues jumped to more than 55% in 2024 from 26% in 2010. The momentum continued this year, with total client assets across both segments reaching $8.9 trillion by September-end. This brings Morgan Stanley closer to its longstanding goal of $10 trillion in asset management set by former CEO James Gorman.
GS & MS: Price Performance, Valuation & Other Comparisons
Over the past six months, shares of Goldman and Morgan Stanley have gained 35.8% and 32.3%, respectively.
GS & MS Six-Month Price Performance
Image Source: Zacks Investment Research
Both outpaced the Zacks Investment Bank industry and the S&P 500 Index. In terms of investor sentiments, Goldman clearly has the edge over MS.
In terms of valuation, Goldman is currently trading at a 12-month forward price-to-earnings (P/E) of 16.34X. The MS stock, on the other hand, is currently trading at a 12-month forward P/E of 17.29X.
P/E F12M
Image Source: Zacks Investment Research
Further, both are trading at a premium compared with the industry average of 15.09X. So, Goldman is inexpensive compared with Morgan Stanley.
GS’s dividend yield of 1.78% is lower than Morgan Stanley’s 2.23%. Moreover, GS’ dividend yield is lower than the industry’s average dividend yield of 1.79%, while Morgan Stanley offers a superior dividend yield than the industry.
Dividend Yield
Image Source: Zacks Investment Research
Further, Goldman’s return on equity (ROE) of 15.29% is below Morgan Stanley’s 16.4%. This reflects Morgan Stanley’s efficient use of shareholder funds to generate profits.
ROE
Image Source: Zacks Investment Research
How Do Estimates Compare for GS & MS?
The Zacks Consensus Estimate for GS’ 2025 revenues implies a 10.8% year-over-year rise, while for 2026, the metric is expected to grow 6%. Likewise, the consensus estimate for 2025 earnings indicates 20.8% growth, while the same is anticipated to rise 12.6% in 2026. Earnings estimates for both years have been revised upward over the past seven days.
Estimate Revision
Image Source: Zacks Investment Research
On the contrary, analysts are slightly more bullish on Morgan Stanley’s prospects this year. The consensus mark for 2025 and 2026 revenues suggests a year-over-year jump of 13.4% and 4.4%, respectively. Also, the consensus estimate for earnings suggests a 24.3% and 5.4% increase for 2025 and 2026, respectively. Earnings estimates for both years have been revised upward over the past week.
Estimate Revision
Image Source: Zacks Investment Research
Goldman or Morgan Stanley: Which IB Stock is a Smarter Bet?
Goldman’s organic efforts to grow its IB income and strategic buyouts alongside efforts to strengthen the AWM segment are likely to bolster its financials. Further, its attractive valuation can offer a higher margin of safety for value investors.
By contrast, Morgan Stanley offers greater upside potential, driven by stronger projected revenue and earnings growth, a robust deal pipeline and continued expansion in wealth and asset management. Despite its higher valuation, the success of its strategic diversification efforts, superior dividend yield and capital allocation make it an attractive pick for long-term, growth-oriented investors.
At present, Goldman carries a Zacks Rank #3 (Hold) while Morgan Stanley carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.